diethylcarbamazine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

diethylcarbamazine has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amidon, GL; Price, JC; Talattof, A	1

Other Studies

1 other study(ies) available for diethylcarbamazine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

Article	Year
Gastrointestinal Motility Variation and Implications for Plasma Level Variation: Oral Drug Products. Molecular pharmaceutics, 2016, Feb-01, Volume: 13, Issue:2 Topics: Administration, Oral; Anticholesteremic Agents; Computer Simulation; Diethylcarbamazine; Fatty Acids, Monounsaturated; Fluorouracil; Fluvastatin; Gastric Emptying; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Immunosuppressive Agents; Indoles; Intestinal Absorption; Lipoxygenase Inhibitors; Male; Models, Biological; Tissue Distribution	2016

Article

Year

Gastrointestinal Motility Variation and Implications for Plasma Level Variation: Oral Drug Products.

Molecular pharmaceutics, 2016, Feb-01, Volume: 13, Issue:2

Topics: Administration, Oral; Anticholesteremic Agents; Computer Simulation; Diethylcarbamazine; Fatty Acids, Monounsaturated; Fluorouracil; Fluvastatin; Gastric Emptying; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Immunosuppressive Agents; Indoles; Intestinal Absorption; Lipoxygenase Inhibitors; Male; Models, Biological; Tissue Distribution

2016